10-K Filing

BENITEC BIOPHARMA INC. CIK: 1808898 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001193125-21-276758`
Period End Date	20210630
Filing Date	20210920
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	d182332d10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 53 Income Statement 38 Cash Flow Statement 45 Stockholders Equity 18

Balance Sheet 53 line items

Line Item	Tag	Value	Unit	Period
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.72M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.77M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	8.17M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	1.11M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	1.11M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	8.17M	shares	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$25.00K	USD	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$59.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$814.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$949.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.81M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.61M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$374.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$375.00K	USD	Point-in-time
Deposits	`DepositAssets`	$9.00K	USD	Point-in-time
Deposits	`DepositAssets`	$9.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$185.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$202.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$395.00K	USD	Point-in-time
Total assets	`Assets`	$21.38M	USD	Point-in-time
Total assets	`Assets`	$11.59M	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$880.00K	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$741.00K	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$276.00K	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$203.00K	USD	Point-in-time
Lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$213.00K	USD	Point-in-time
Lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$192.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.14M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.37M	USD	Point-in-time
Lease liabilities, less current portion	`OperatingLeaseLiabilityNoncurrent`	$213.00K	USD	Point-in-time
Lease liabilities, less current portion	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$1.37M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.35M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.0001 par value10,000,000 shares authorized; 8,171,690 and 1,108,374 shares issued and outstanding at June 30, 2021 and 2020, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.0001 par value10,000,000 shares authorized; 8,171,690 and 1,108,374 shares issued and outstanding at June 30, 2021 and 2020, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$128.83M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$151.58M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-130.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-116.64M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.95M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.46M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.24M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.59M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.38M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.59M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Revenues from customers	`RevenueFromContractWithCustomerIncludingAssessedTax`	$59.00K	USD	Annual
Revenues from customers	`RevenueFromContractWithCustomerIncludingAssessedTax`	$97.00K	USD	Annual
Government research and development grants	`RevenueNotFromContractWithCustomerOther`	-	USD	Annual
Government research and development grants	`RevenueNotFromContractWithCustomerOther`	$5.00K	USD	Annual
Total revenues	`Revenues`	$59.00K	USD	Annual
Total revenues	`Revenues`	$102.00K	USD	Annual
Royalties and license fees	`RoyaltiesAndLicenseFees`	$123.00K	USD	Annual
Royalties and license fees	`RoyaltiesAndLicenseFees`	$-185.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$7.02M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.00M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.51M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.57M	USD	Annual
Total operating expenses	`OperatingExpenses`	$13.65M	USD	Annual
Total operating expenses	`OperatingExpenses`	$8.38M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-8.28M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-13.60M	USD	Annual
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-88.00K	USD	Annual
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-333.00K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$-6.00K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$62.00K	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$34.00K	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$37.00K	USD	Annual
Unrealized gain (loss) on investment	`UnrealizedGainLossOnInvestments`	$16.00K	USD	Annual
Unrealized gain (loss) on investment	`UnrealizedGainLossOnInvestments`	$-1.00K	USD	Annual
Total other income (loss), net	`NonoperatingIncomeExpense`	$7.00K	USD	Annual
Total other income (loss), net	`NonoperatingIncomeExpense`	$-286.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-13.88M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.27M	USD	Annual
Unrealized foreign currency translation gain (loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$498.00K	USD	Annual
Unrealized foreign currency translation gain (loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-89.00K	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$498.00K	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-89.00K	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-13.38M	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.36M	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.10	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.23	USD	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.02M	shares	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.30M	shares	Annual

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-13.88M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.27M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$231.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$190.00K	USD	Annual
Amortization of right-of-use assets	`AmortizationOfRightOfUseAssets`	$184.00K	USD	Annual
Amortization of right-of-use assets	`AmortizationOfRightOfUseAssets`	$193.00K	USD	Annual
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.00K	USD	Annual
Unrealized (gain) loss on investment	`UnrealizedGainLossOnInvestments`	$16.00K	USD	Annual
Unrealized (gain) loss on investment	`UnrealizedGainLossOnInvestments`	$-1.00K	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$237.00K	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$634.00K	USD	Annual
Trade and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-2.40M	USD	Annual
Trade and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-28.00K	USD	Annual
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.00K	USD	Annual
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$457.00K	USD	Annual
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$55.00K	USD	Annual
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$-1.70M	USD	Annual
Accrued employee benefit payable	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$57.00K	USD	Annual
Accrued employee benefit payable	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$121.00K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiabilities`	$-192.00K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiabilities`	$-174.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.83M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.54M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$95.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$221.00K	USD	Annual
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-221.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-94.00K	USD	Annual
Proceeds from issues of shares and pre-funded warrants	`ProceedsFromIssuanceOfCommonStock`	$25.75M	USD	Annual
Proceeds from issues of shares and pre-funded warrants	`ProceedsFromIssuanceOfCommonStock`	$2.25M	USD	Annual
Share issue transaction costs	`PaymentsOfStockIssuanceCosts`	$3.23M	USD	Annual
Share issue transaction costs	`PaymentsOfStockIssuanceCosts`	$480.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.52M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.77M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$9.47M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-5.86M	USD	Annual
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$15.72M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$9.80M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$19.77M	USD	Point-in-time
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$499.00K	USD	Annual
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-58.00K	USD	Annual
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$15.72M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$9.80M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$19.77M	USD	Point-in-time
Initial measurement of operating lease right-of-use assets and liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$579.00K	USD	Annual

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Payments For Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$3.23M	USD	Annual
Payments For Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$480.00K	USD	Annual
Balance at the beginning	`StockholdersEquity`	$10.24M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$20.01M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$16.59M	USD	Point-in-time
Common stock sold for cash, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$22.52M	USD	Annual
Common stock sold for cash, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$1.72M	USD	Annual
Issuance and exercise of pre-funded warrants, net of transaction costs of $240	`IssuanceAndExerciseOfPrefundedWarrantsNetOfTransactionCosts`	$50.00K	USD	Annual
Exercise of pre-funded warrants	`WarrantsExercisedValueDuringThePeriod`	$3.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$237.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$634.00K	USD	Annual
Foreign currency translation loss (Gain)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$498.00K	USD	Annual
Foreign currency translation loss (Gain)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-89.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-13.88M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.27M	USD	Annual
Balance at end	`StockholdersEquity`	$10.24M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$20.01M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$16.59M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.